Clinical characterization of the first Belgian SCN5A founder mutation cohort.
Sieliwonczyk E, Alaerts M, Robyns T, Schepers D, Claes C, Corveleyn A, Willems R, Van Craenenbroeck EM, Simons E, Nijak A, Vandendriessche B, Mortier G, Vrints C, Koopman P, Heidbuchel H, Van Laer L, Saenen J, Loeys B.
Sieliwonczyk E, et al.
Europace. 2021 Jun 7;23(6):918-927. doi: 10.1093/europace/euaa305.
Europace. 2021.
PMID: 33221854